Showing results (21-30 of 102) with videos related to
Sort By:
Pageof 11
European Journal of Pharmacology|September 27, 2015
PPARα regulates tumor progression, foe or friend?Jiaming Gao, Shuping Yuan, Jianhua Jin, et al.Theriogenology|April 21, 2023
Proteomic analysis reveals the potential positive effects of Mito-TEMPO on ram sperm motility and fertility during cryopreservationLei Shi, Juanjuan Shi, Jingjuan Feng, et al.European Journal of Pharmacology|June 1, 2019
Metformin inhibits PPARδ agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cellsJiajun Ding, Qian Gou, Jianhua Jin, et al.JAMA Network Open|April 7, 2021
Cost-effectiveness of Atezolizumab Plus Bevacizumab vs Sorafenib for Patients With Unresectable or Metastatic Hepatocellular CarcinomaXin Zhang, Jingjing Wang, Juanjuan Shi, et al.European Journal of Pharmacology|March 29, 2026
Clofibrate inhibits tumor immune escape by increasing macrophage phagocytosisHuijie Wang, Yelei Wang, Yinghan Li, et al.Cell Communication and Signaling : CCS|September 8, 2021
Role of autophagy on cancer immune escapeYalan Duan, Xiaoqing Tian, Qian Liu, et al.Canadian Journal of Gastroenterology & Hepatology|March 31, 2022
A Meta-Analysis of Statin Use and Risk of Hepatocellular CarcinomaYikai Wang, Wenjun Wang, Muqi Wang, et al.Cancer Science|April 25, 2023
PPARγ inhibited tumor immune escape by inducing PD-L1 autophagic degradationQian Gou, Suning Che, Mingjun Chen, et al.European Journal of Pharmacology|September 11, 2016
Pioglitazone inhibits EGFR/MDM2 signaling-mediated PPARγ degradationJuanjuan Shi, Wenbo Zhang, Mengli You, et al.Journal of Clinical Gastroenterology|March 22, 2022
Aspirin Use and the Risk of Hepatocellular Carcinoma: A Meta-analysisYikai Wang, Muqi Wang, Chenrui Liu, et al.Pageof 11